Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MC-1101 in Non-exudative Age-Related Macular Degeneration
NCT02127463Phase 3Unknown
- Sponsor
- MacuCLEAR
- Start
- Apr 2014
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydralazine in age-related macular degeneration (AMD), sponsored by MacuCLEAR. Status: unknown.
02
Drugs
hydralazine
03
Conditions
age-related macular degeneration (AMD)
Beyond the preview
Go deeper on NCT02127463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02127463.